[Suppression of labor contractions by intravenous hexoprenaline: a preliminary investigation in the Paarl Hospital].
D000284:Administration, Oral; D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D002396:Catechols / Q000008:administration & dosage / Q000627:therapeutic use; D003864:Depression, Chemical; D004983:Ethanolamines / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D009119:Muscle Contraction / Q000187:drug effects; D007744:Obstetric Labor Complications / Q000188:drug therapy* / Q000503:physiopathology; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D010627:Phenethylamines / Q000008:administration & dosage* / Q000627:therapeutic use; D010923:Placenta Previa / Q000188:drug therapy; D006831:Polyhydramnios / Q000188:drug therapy; D011247:Pregnancy; D014593:Uterine Inertia / Q000188:drug therapy; D014599:Uterus / Q000503:physiopathology
D000318:Adrenergic beta-Agonists; D002396:Catechols; D004983:Ethanolamines; D010627:Phenethylamines
Onderdrukking van kraamkontraksies deur binneaarse heksoprenalien: 'n voorlopige ondersoek in die Paarl-Hospitaal